Thus, the data support our conclusion that silencing Iris also converts MSCs within a syngeneic tumor from promoters into suppressors of tumor growth and raises the very interesting possibility that inhibiting IRIS expression and/or activity in patients with established TNBC tumors could trigger death from the inside of the tumors by converting the pro-tumor MSCs into an anti-tumor entity. This evidence concerns the gene BRCA1 and neoplasm.